• Pilot clinical performance data (1H-14); • Retrospective / prognostic 9 year patient record clinical study (1H-14) • Clinical Performance studies to support CLIA registration (1H-14) • Commercial Launch as a Laboratory-Developed Test (“LDT”) under CLIA (2H- 2014)
Eltoprazine
• Evaluate best indication for commercial development (1H/14) • Initiate Phase 2b Clinical Trial (1H/14) • MJFF Grant Funding (FY-14)